Supprelin LA Alternatives Compared
| Supprelin LA (histrelin) | Tamoxifen | Lupron Depot-PED (leuprolide) |
|
|---|
| Supprelin LA (histrelin) | Tamoxifen | Lupron Depot-PED (leuprolide) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Lupron Depot is a hormone deprivation treatment that may be used for the palliative care of advanced prostate cancer. The main side effects are hot flashes and general pain and it may cause... View more |
Prescription only
Prescribed for Breast Cancer - Adjuvant, Breast Cancer - Metastatic, Breast Cancer, Breast Cancer - Male, Breast Cancer - Palliative, Breast Cancer - Prevention, McCune-Albright Syndrome, Precocious... View more |
Prescription only
Prescribed for Precocious Puberty. Lupron Depot-PED may also be used for purposes not listed in this medication guide. |
Related suggestions Precocious Puberty
Popular comparisons
|
|||||||||||||||||||||||
| More about Supprelin LA (histrelin) | More about Tamoxifen | More about (leuprolide) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Supprelin LA has an average rating of 5.5 out of 10 from a total of 2 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 50% reported a negative effect. |
Tamoxifen has an average rating of 5.6 out of 10 from a total of 97 ratings on Drugs.com. 32% of reviewers reported a positive effect, while 29% reported a negative effect. |
Lupron Depot-PED has an average rating of 5.0 out of 10 from a total of 25 ratings on Drugs.com. 28% of reviewers reported a positive effect, while 40% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Supprelin LA side effects |
View all Tamoxifen side effects |
View all Lupron Depot-PED side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
N/A |
|||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Supprelin LA prices |
View all Tamoxifen prices |
View all Lupron Depot-PED prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other histrelin brands include: Vantas | Soltamox | Other leuprolide brands include: Camcevi, Eligard, Fensolvi, Lupron, Lupron Depot, Lutrate Depot | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
N/A |
231 hours |
4.25 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 282 drugs are known to interact with Supprelin LA:
|
A total of 457 drugs are known to interact with Tamoxifen:
|
A total of 282 drugs are known to interact with Lupron Depot-PED:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
May 03, 2007 |
December 30, 1977 |
N/A |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.